Telemonitoring for patients with COPD: effects are uncertain

Added April 3, 2020

Citation: Kruse C, Pesek B, Anderson M, Brennan K, Comfort H. Telemonitoring to manage chronic obstructive pulmonary disease: systematic literature review. JMIR Medical Informatics 2019; 7(1): e11496

What is this? The COVID-19 pandemic is placing a great strain on health systems, affecting routine health and social care for people with other conditions. Ways to deliver this care remotely might include telemonitoring for conditions such as chronic obstructive pulmonary disease (COPD).

In this systematic review, the authors searched for studies of the use of telemonitoring to manage patients with COPD. They restricted their search to articles published in English from 1 February 2011 to 1 February 2017. They identified 29 eligible studies.

What works: Nothing noted.

What doesn’t work: Nothing noted.

What’s uncertain: The effects of telemonitoring for patients with COPD are uncetain. Although some studies reported that telemonitoring for patients with COPD reduced the need for in-person visits, improved disease management and bolstered patient-provider relationship; other studies did not find benefits, and important barriers included low-quality data, increased workload for providers and cost.

 

 

Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.

Share